Reproducibility of bone mineral density measurement in daily practice

被引:73
作者
Lodder, MC
Lems, WF
Ader, HJ
Marthinsen, AE
van Coeverden, SCCM
Lips, P
Netelenbos, JC
Dijkmans, BAC
Roos, JC
机构
[1] Vrije Univ Amsterdam, Dept Rheumatol, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Dept Clin Epidemiol & Biostat, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Paediat, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Endocrinol, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Dept Nucl Med, Med Ctr, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1136/ard.2002.005678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Bone mineral density (BMD) measurements are frequently performed repeatedly for each patient. Subsequent BMD measurements allow reproducibility to be assessed. Objective: To examine the reproducibility of BMD by dual energy x ray absorptiometry (DXA) and to investigate the practical value of different measures of reproducibility in a group of postmenopausal women. Methods: Ninety five women, mean age 59.9 years, underwent two subsequent BMD measurements of spine and hip. Reproducibility was expressed as smallest detectable difference (SDD), coefficient of variation (CV), and intraclass correlation coefficient (ICC). Sources of variation were investigated by multilevel analysis. Results: The median interval between measurements was 0 days ( range 0 - 45). The mean difference (SD) between the measurements (g/cm(2)) was -0.001 (0.02) and -0.0004 (0.02) at L1- 4 and the total hip, respectively. At L1- 4 and the total hip, SDD (g/cm(2)) was +/- 0.05 and +/- 0.04 and CV (%) was 1.92 and 1.59, respectively. The ICC at spine and hip was 0.99. Conclusions: Reproducibility in the postmenopausal women studied was good. In a repeated DXA scan a BMD change exceeding 2root2CV (%), the least significant change (LSC), or the SDD should be regarded as significant. Use of the SDD is preferable to use of the CV and LSC (%) because of its independence from BMD and its expression in absolute units. Expressed as SDD, a BMD change of at least +/- 0.05 g/cm(2) at L1- 4 and +/- 0.04 g/cm(2) at the total hip should be considered significant.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 31 条
[1]   Bone densitometry and the diagnosis of osteoporosis [J].
Blake, GM ;
Fogelman, I .
SEMINARS IN NUCLEAR MEDICINE, 2001, 31 (01) :69-81
[2]  
BLAKE GM, 1999, ASSESSMENT INSTRUMEN, P147
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]   Primary prevention of gluccocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone [J].
Boutsen, Y ;
Jamart, J ;
Esselinckx, W ;
Devogelaer, JP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :104-112
[5]  
Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO
[6]  
2-K
[7]   SHOULD PERIMENOPAUSAL WOMEN BE SCREENED FOR OSTEOPOROSIS [J].
CUMMINGS, SR ;
BLACK, D .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :817-823
[8]   CYCLICAL ETIDRONATE PLUS ERGOCALCIFEROL PREVENTS GLUCOCORTICOID-INDUCED BONE LOSS IN POSTMENOPAUSAL WOMEN [J].
DIAMOND, T ;
MCGUIGAN, L ;
BARBAGALLO, S ;
BRYANT, C .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05) :459-463
[9]   Assessment of bone density and bone loss [J].
Eastell, R .
OSTEOPOROSIS INTERNATIONAL, 1996, 6 :3-5
[10]  
EL-HAJJ FULEIHAN G, 1995, J BONE MINER RES, V10, P1004